Search - tctmd.com

Displaying 21 - 40 of 49

Sort: Relevancy | Date

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News EuroPCR 2023

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

Caitlin E. Cox

May 16, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

Presentation Miami Valves 2023

Bioprosthetic Valve Fracture in Patients Undergoing Valve-in-Valve TAVR for Failed Surgical Valves using SAPIEN 3/Ultra Valves: Insights From TVT Registry

Presenter: Santiago Garcia

February 02, 2023

News Daily News

Comparing TAVI Devices: Much Overlap, Some Nuances to Guide Care

Caitlin E. Cox

December 19, 2022

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Daily News

Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD

L.A. McKeown

November 04, 2021

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Todd Neale

July 23, 2021

Good TAVI Results Seen Bicuspid Aortic Stenosis TVT Registry.PNG

News Conference News EuroPCR 2021

Good TAVI Results Seen in Bicuspid Aortic Stenosis: TVT Registry

Todd Neale

May 20, 2021

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Presentation TVT 2020

Real-world experience with the SAPIEN 3 Ultra TAVR: A propensity matched analysis from the United States

Presenter: Tamim Nazif

June 20, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

Advertisement

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Bioprosthetic Valve Fracture in Patients Undergoing Valve-in-Valve TAVR for Failed Surgical Valves using SAPIEN 3/Ultra Valves: Insights From TVT Registry

Comparing TAVI Devices: Much Overlap, Some Nuances to Guide Care

Valve Fracture for ViV TAVI Linked With Higher Mortality

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Intravascular Lithotripsy May Facilitate TAVI in Patients With PAD

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Good TAVI Results Seen in Bicuspid Aortic Stenosis: TVT Registry

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Which TAVR Device Is Best? Review Tackles Optimal Selection

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Real-world experience with the SAPIEN 3 Ultra TAVR: A propensity matched analysis from the United States

Newer TAVR Devices Reassure in Failed Surgical Valves

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content